Microbio Co

Microbio Co Liabilities

The The Liabilities of Microbio Co (4128.TWO) as of Nov 19, 2026 is 2.13 B TWD. In the previous year, The Liabilities was 2.06 B TWD — a change of 3.47% (higher).

Liabilities

2.13 BTWD

YoY

3.47%

Last updated:

In 2025, Microbio Co's total liabilities amounted to 2.13 B TWD, a 3.47% difference from the 2.06 B TWD total liabilities in the previous year.

The Microbio Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
555.11 M TWD
Jan 1, 2019
1.01 B TWD
Jan 1, 2020
1.07 B TWD
Jan 1, 2021
1.17 B TWD
Jan 1, 2022
1.08 B TWD
Jan 1, 2023
1.23 B TWD
Jan 1, 2024
2.06 B TWD
Jan 1, 2025
2.13 B TWD
The Microbio Co Liabilities history
YEARLiabilitiesYoY
2.13 BTWD+3.47%
2.06 BTWD+66.68%
1.23 BTWD+14.07%
1.08 BTWD-7.73%
1.17 BTWD+9.28%
1.07 BTWD+6.37%
1.01 BTWD+81.80%
555.11 MTWD-35.41%
859.50 MTWD+1.82%
844.17 MTWD-5.09%
889.40 MTWD+37.71%
645.86 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion. Microbio Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Microbio Co's Liabilities

Microbio Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Microbio Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Microbio Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Microbio Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Microbio Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Microbio Co stock

The Liabilities of Microbio Co is 2.13 B TWD in 2025.

The Liabilities of Microbio Co changed from 2.06 B TWD to 2.13 B TWD, representing a 3.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Microbio Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Microbio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Microbio Co

All Key Metrics — Microbio Co